Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncternal Therapeutics (ONCT)
:ONCT
Holding ONCT?
Track your performance easily
ONCT Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncternal Therapeutics News
PremiumCompany Announcements
Oncternal Therapeutics Reports Q3 2024 Earnings
PremiumCompany Announcements
Oncternal Therapeutics Announces Workforce Reduction and Executive Changes
PremiumCompany Announcements
Oncternal Therapeutics Restructures Amid Clinical SetbacksOwnership Overview
― Insiders
1.10% Mutual Funds
― Other Institutional Investors
97.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ONCT FAQ
What was Oncternal Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Oncternal Therapeutics’s market cap?
Currently, no data Available
When is Oncternal Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oncternal Therapeutics’s earnings last quarter?
Currently, no data Available
Is Oncternal Therapeutics overvalued?
According to Wall Street analysts Oncternal Therapeutics’s price is currently Undervalued.
Does Oncternal Therapeutics pay dividends?
Oncternal Therapeutics does not currently pay dividends.
What is Oncternal Therapeutics’s EPS estimate?
Oncternal Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncternal Therapeutics have?
Currently, no data Available
What happened to Oncternal Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncternal Therapeutics?
Currently, no hedge funds are holding shares in ONCT
---
---